In conclusion, our study revealed few effects of the eIF2α+/S51A genotype on disease progression in the 5xFAD mouse model of AD with the exception of a possible amelioration of 5xFAD-related motor hyperactivity. This evidence concerns the gene EIF2A and Alzheimer disease.